Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Codiak BioSciences Inc. (CDAK)

19.1   1.05 (5.82%) 09-23 15:02
Open: 18.3 Pre. Close: 18.05
High: 19.335 Low: 17.89
Volume: 35,015 Market Cap: 427M
Codiak BioSciences, Inc. is harnessing exosomesÂ?natural intercellular messengersÂ?to pioneer a new class of biologic medicines, exosome therapeutics. It develops the engEx Platform, versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. The company's two lead engEx product candidates, exoSTING and exoIL-12. Its engEx Platform has the potential to produce a broad pipeline of product candidates for the treatment of diseases with high unmet medical need, including in the areas of oncology, immune-based diseases, metabolic and fibrotic disorders, neurodegenerative disorders, and rare diseases. Codiak BioSciences, Inc. has a strategic collaboration with the Ragon Institute of MGH, MIT and Harvard to investigate the potential of exoVACC vaccine platform for SARS-CoV-2 and human immunodeficiency virus. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.652 - 19.77 19.77 - 19.858
Low: 18.228 - 18.379 18.379 - 18.491
Close: 18.689 - 18.915 18.915 - 19.083

Technical analysis

as of: 2021-09-23 2:40:13 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 22.01     One year: 23.91
Support: Support1: 16.22    Support2: 13.50
Resistance: Resistance1: 18.85    Resistance2: 20.47
Pivot: 17.76
Moving Average: MA(5): 18.85     MA(20): 17.56
MA(100): 19.34     MA(250):
MACD: MACD(12,26): 0.09     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 65.42     %D(3): 74.75
RSI: RSI(14): 49.78
52-week: High: 37.85  Low: 7.90  Change(%): 48.9
Average Vol(K): 3-Month: 307239  10-Days: 9071

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CDAK has closed below upper band by 41.8%. Bollinger Bands are 44.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to CDAK's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 22 Sep 2021
Codiak (CDAK) falls 4.45% on Moderate Volume September 22 - Equities.com

Tue, 21 Sep 2021
Codiak (CDAK) falls 1.00% for September 21 - Equities.com

Tue, 21 Sep 2021
$CDAK Codiak Biosciences Inc Says Entered Into Second Amendment To Loan And Security Agreement - CML News

Thu, 09 Sep 2021
Codiak (CDAK) falls 0.94% for September 9 - Equities.com

Thu, 05 Aug 2021
Codiak BioSciences Reports Second Quarter 2021 Financial - GlobeNewswire

Wed, 07 Jul 2021
Codiak BioSciences to Present at the Virtual William Blair Biotech Focus Conference 2021 - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 22
Shares Float (M) 14
% Held by Insiders 0.09
% Held by Institutions 82.02
Shares Short (K) 881
Shares Short P. Month (K) 1,170

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -504.04
Return on Assets (ttm) -36.8
Return on Equity (ttm) -442.3
Qtrly Rev. Growth 375.9
Gross Profit (p.s.) -3.225
Sales Per Share 0.757
EBITDA (p.s.) -3.580
Qtrly Earnings Growth
Operating Cash Flow (M) -86
Levered Free Cash Flow (M) -49

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 23.85
Price to Cash Flow -4.61

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.